Building the future of Alzheimer’s research and innovation at UBC
Catalyzed by a transformational donation, the Dementia Therapeutics Innovation Initiative is advancing target discovery for dementia and Alzheimer’s Disease.
Despite increased research on Alzheimer’s disease and over 200 clinical trials for promising candidate drugs, very few therapeutics have emerged.
Our vision is to achieve a disease-modifying treatment for Alzheimer’s disease that is discovered, developed, and tested right here at UBC.
Latest Post
-
Naming of the Kenneth W. McArthur Neurodegenerative Research Floor
The Dementia Therapeutics Innovation Initiative (DTII) was launched in 2025 thanks to the philanthropy of Kenneth W. McArthur. A recent Give UBC story ‘Loyal donor-alum’s generosity advances Alzheimer’s research at UBC’ highlights the generosity of the McArthurs and the Aune Foundation, whose transformational support is helping to advance innovative Alzheimer’s research and strengthen UBC’s efforts…